Guangdong Ruitai Pharmaceuticals reicht am 22. Mai einen IPO-Antrag bei der Hong Kong Stock Exchange ein

GateNews
Laut Einreichungen der Hong Kong Exchanges and Clearing hat Guangdong Ruitai Pharmaceuticals Co., Ltd. am 22. Mai seinen IPO-Antrag an die Hong Kong Stock Exchange gestellt. CITIC Securities ist der alleinige Sponsor für die Notierung.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Kommentieren
0/400
Keine Kommentare